Literature DB >> 28633343

An unknown reaction to pembrolizumab: giant cell arteritis.

I Micaily1, M Chernoff2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28633343     DOI： 10.1093/annonc/mdx306

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  12 in total

Review 1.  The relationships between cancer and autoimmune rheumatic diseases.

Authors:  Laura C Cappelli; Ami A Shah
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-02-03       Impact factor: 4.098

2.  Diagnosis and Management of Rare Immune-Related Adverse Events.

Authors:  Sara R Schoenfeld; Mary E Aronow; Rebecca Karp Leaf; Michael Dougan; Kerry L Reynolds
Journal:  Oncologist       Date:  2019-11-06

Review 3.  Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management.

Authors:  Yu-Wen Zhou; Qian Xu; Yan Wang; Ruo-Lan Xia; Ji-Yan Liu; Xue-Lei Ma
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

4.  The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI.

Authors:  Arash Rashidi; Chintan Shah; Miroslav Sekulic
Journal:  Kidney360       Date:  2022-01-13

Review 5.  Ocular Toxicity of Targeted Anticancer Agents.

Authors:  Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal:  Drugs       Date:  2021-03-31       Impact factor: 9.546

6.  Management of immune checkpoint inhibitor-related rheumatic adverse events.

Authors:  Jiaxin Zhou; Hanping Wang; Xiaoxiao Guo; Qian Wang; Lian Duan; Xiaoyan Si; Li Zhang; Xiaowei Liu; Yue Li; Wen Zhang; Li Zhang
Journal:  Thorac Cancer       Date:  2019-11-24       Impact factor: 3.500

7.  Clinical characteristics of rheumatic syndromes associated with checkpoint inhibitors therapy.

Authors:  Marie Kostine; Marie-Elise Truchetet; Thierry Schaeverbeke
Journal:  Rheumatology (Oxford)       Date:  2019-12-01       Impact factor: 7.580

Review 8.  Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review.

Authors:  Caberry W Yu; Matthew Yau; Natalie Mezey; Ishraq Joarder; Jonathan A Micieli
Journal:  Eye Brain       Date:  2020-11-03

9.  Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series.

Authors:  Kendall F Moseley; Jarushka Naidoo; Clifton O Bingham; Michael A Carducci; Patrick M Forde; Geoffrey T Gibney; Evan J Lipson; Ami A Shah; William H Sharfman; Laura C Cappelli
Journal:  J Immunother Cancer       Date:  2018-10-11       Impact factor: 13.751

Review 10.  [Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors].

Authors:  Jiaxin Zhou; Qian Wang; Lian Duan; Xiaoyan Si; Li Zhang; Xiaowei Liu; Yue Li; Hanping Wang; Xiaoxiao Guo; Wen Zhang; Li Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2019-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.